We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNO
12951
DELISTED
Soleno Therapeutics
SLNO
$32K ﹤0.01%
9,642
-350
-4% -$1.81K
SMMT icon
12952
CALL
Summit Therapeutics
SMMT
$11.1B
$32K ﹤0.01%
13,100
+200
+2% +$504
VCNX
12953
CALL
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$32K ﹤0.01%
117
+56
+92% +$15.5K
KRNLW
12954
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$32K ﹤0.01%
127,914
+2,090
+2% +$714
TRVN
12955
DELISTED
Trevena, Inc.
TRVN
$32K ﹤0.01%
94
-159
-63% -$50.2K
SIEN
12956
CALL
DELISTED
Sientra, Inc.
SIEN
$32K ﹤0.01%
+1,430
New +$39.2K
MARK
12957
PUT
DELISTED
Remark Holdings, Inc.
MARK
$32K ﹤0.01%
3,910
-2,080
-35% -$17.4K
TCBP
12958
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
0
MBII
12959
DELISTED
Marrone Bio Innovations, Inc.
MBII
$32K ﹤0.01%
29,791
-85,222
-74% -$64.4K
CEI
12960
DELISTED
Camber Energy, Inc
CEI
$32K ﹤0.01%
757
-5,170
-87% -$190K
AQST icon
12961
PUT
Aquestive Therapeutics
AQST
$494M
$31K ﹤0.01%
11,900
-47,000
-80% -$137K
FTFT icon
12962
Future FinTech Group
FTFT
$1.47M
$31K ﹤0.01%
52
-13
-20% -$8.78K
HOUR icon
12963
Hour Loop
HOUR
$68.3M
$31K ﹤0.01%
+10,276
New +$35K
NCEL
12964
NewcelX Ltd
NCEL
$17.8M
$31K ﹤0.01%
+54
New +$25.6K
PTN
12965
Palatin Technologies
PTN
$13.8M
$31K ﹤0.01%
+54
New +$28.2K
RIGL icon
12966
PUT
Rigel Pharmaceuticals
RIGL
$750M
$31K ﹤0.01%
1,030
-2,160
-68% -$58.5K
VANI icon
12967
Vivani Medical
VANI
$122M
$31K ﹤0.01%
7,298
-11,468
-61% -$48.2K
VSA
12968
VisionSys AI
VSA
$10.6M
$31K ﹤0.01%
+25
New +$29K
BIMI
12969
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$31K ﹤0.01%
+2,269
New +$37K
ATNX
12970
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$31K ﹤0.01%
1,880
-2,550
-58% -$49.9K
TUEM
12971
PUT
DELISTED
Tuesday Morning Corp
TUEM
$31K ﹤0.01%
933
-1,787
-66% -$86K
EMWP
12972
DELISTED
Eros Media World PLC
EMWP
$31K ﹤0.01%
11,094
-1,113
-9% -$4.64K
MACUW
12973
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
$31K ﹤0.01%
363,791
-36,209
-9% -$5.48K
BSQR
12974
CALL
DELISTED
BSQUARE Corporation
BSQR
$31K ﹤0.01%
17,700
-13,100
-43% -$21.5K
ADAP
12975
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$30K ﹤0.01%
+14,800
New +$39.9K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.